A 10-year analysis of primary cutaneous malignant melanoma with sentinel lymph node biopsy and long-term follow-up

International Journal of Dermatology

Volumn 52, Issue 2, 2013, Pages 220-230

  Beger, Josefine ^a   Hansel, Gesina ^a   Krönert, Claudia ^a   Fuchs, Martin ^b   Tanner, Carmen ^b   Schönlebe, Jaqueline ^a   Werner, Carmen ^b   Nowak, Andreas ^a   Haroske, Gunter ^a   Witzigmann, Helmut ^a   Wollina, Uwe ^a  

^a ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN TC 99M COLLOID;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CAUSE OF DEATH; CUTANEOUS MELANOMA; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; LYMPH NODE METASTASIS; LYMPHEDEMA; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; NERVE LESION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SATELLITE METASTASIS; SENTINEL LYMPH NODE BIOPSY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR LOCALIZATION; TUMOR VOLUME; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; RECURRENCE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84873050720     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2012.05706.x     Document Type: Article

References (39)

1. Balch CM, Soong SJ, Atkins MB, et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 2004; 54: 131-149.
2. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
3. Morton DL, Wanek L, Nizze JA, et al. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg 1991; 214: 491-499.
4. Morton DL, Thompson JF, Cochran A, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 28: 1307-1317.
5. Garbe C, Schadendorf D, Scholz W, et al. Short German guidelines: malignant melanoma. J Dtsch Dermatol Ges 2008; 6(Suppl 1): S9-S14.
6. Burroni M, Corona R, Dell'Eva G, et al. Melanoma computer-aided diagnosis: reliability and feasibility study. Clin Cancer Res 2004; 10: 1881-1886.
7. Wollina U, Burroni M, Torricelli R, et al. Digital dermoscopy in clinical practice: a three-centre analysis. Skin Res Technol 2007; 13: 133-142.
8. Seebacher C, Steinert W, Köstler P, Koch R. [Results of treatment of malignant melanoma - a computer analysis of 772 patients] [German]. Dermatol Monatsschr 1990; 176: 337-344.
9. Garbe C, Büttner P, Ellwanger U, et al. [The Malignant Melanoma Central Register of the German Society of Dermatology 1983-1993. Epidemiologic developments and current therapeutic management of malignant melanoma of the skin] [German]. Hautarzt 1995; 46: 683-692.
10. Spanknebel K, Coit DG, Bieligk SC, et al. Characterization of micrometastatic disease in melanoma in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol 2005; 29: 305-317.
11. Balch CM, Soong SJ, Gershewald JE. Prognostic factors analysis of 17, 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 17: 3622-3643.
12. Garbe C, Schadendorf D, Scholz W, et al. Short guideline - malignant melanoma of skin. J Dtsch Dermatol Ges 2008; 6: 9-15.
13. Sondak VK, Zager JS, Messina JL. Sentinel lymph node biopsy as the standard of care for cutaneous melanoma. Clin Adv Hematol Oncol 2007; 5: 483-490.
14. Phan GQ, Messina JL, Sondak VK, Zager JS. Sentinel lymph node biopsy for melanoma: indications and rationale. Cancer Control 2009; 16: 234-239.
15. Bagaria SP, Faries MB, Morton DL. Sentinel lymph node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute. J Surg Oncol 2010; 101: 669-676.
16. Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995; 5: 255-260.
17. Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early stage melanoma: accuracy and morbidity in MSLT-1, an international multicenter trial. Ann Surg 2005; 3: 302-311.
18. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996; 223: 217-224.
19. Mattson J, Bergkvist L, Abdiu A, et al. Sentinel node biopsy in malignant melanoma: swedish experiences 1997-2005. Acta Oncol 2008; 47: 1519-1525.
20. Testori A, DecSalvo GL, Montesco MC, et al. Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1.313 patients (SOLISM-IMI). Ann Surg Oncol 2009; 16: 2018-2027.
21. Scoggins CR, Martin RC, Ross MI, et al. Factors associated with false-negative sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol 2010; 17: 709-717.
22. Valsecchi ME, Silbermins D, de Rosa N, et al. Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis. J Clin Oncol 2011; 29: 1479-1487.
23. Conway WC, Faries MB, Nicholl MB, et al. Age-related lymphatic dysfunction in melanoma patients. Ann Surg Oncol 2009; 16: 1548-1552.
24. Vermeeren L, van der Ploeg IM, Olmos RA, et al. SPECT/CT for preoperative sentinel node localization. J Surg Oncol 2010; 101: 184-190.
25. Arens A, Osgina J, Schwipper V, et al. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards.] [German]. Chirurg 2003; 74: 665-670.
26. Rutkowski P, Zurawski Z, Dziewirski W, et al. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection. Eur J Cancer 2006; 42: 159-164.
27. Caracó C, Marone U, Celentano E, et al. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma. Ann Surg Oncol 2007; 14: 2662-2667.
28. Savoia P, Fava P, Caliendo V, et al. Disease progression in melanoma patients with negative sentinel lymph node: does false-negative specimens entirely account for this phenomenon? J Eur Acad Dermatol Venereol 2011; 26: 242-248.
29. Ellis MC, Weerasinghe R, Corless CL, Vetto JT. Sentinel lymph node staging of cutaneous melanoma: predictors and outcome. Am J Surg 2010; 199: 663-668.
30. Sondak VK, Zager JS. Who is to blame for false-negative sentinel node biopsies in melanoma? Ann Surg Oncol 2009; 17: 670-673.
31. Hansel G, Schönlebe J, Haroske G, Wollina U. Late recurrence (10 years or more) of malignant melanoma in south-east Germany (Saxony). A single-centre analysis of 1881 patients with a follow-up of 10 years or more. J Eur Acad Dermatol Venereol 2010; 24: 833-836.
32. Leiter U, Buettner PG, Eigentler TK, et al. Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33, 384 patients in the German Central Melanoma Registry. J Am Acad Dermatol 2012; 66: 37-45.
33. Leiter U, Buettner PG, Bohnenberger K, et al. Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement. Ann Surg Oncol 2010; 17: 128-137.
34. Satzger I, Meier A, Hoy L, et al. Sentinel node dissection delays recurrence and prolongs melanoma-related survival: an analysis of 673 patients from a single center with long-term follow-up. Ann Surg Oncol 2011; 18: 514-520.
35. Brown RF, Ross MI, Edwars MJ, et al. The prognostic significance of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 2010; 17: 3330-3335.
36. Faries MB, Thompson JF, Cochran A, et al. The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I). Ann Surg Oncol 2010; 17: 3324-3329.
37. Pasquali S, Mocellin S, Campana LG, et al. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases: personal experience and literature meta-analysis. Cancer 2010; 116: 1201-1209.
38. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-6206.
39. Weyers W. The magic of numbers: malignant melanoma between science and pseudoscience. Am J Dermatopathol 2011; 33: 371-378.